Thrilled to see the great work from @danielevanbauer lab featured in @NatureBiotech! The discovery that a limited nucleotide pool in HSPCs constrains prime editing is a leap forward in gene editing technology. A huge shoutout to @SbastienLevesq4 and the entire team!
My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). https://t.co/SultcbhT21
My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). https://t.co/SultcbhT21
I am deeply honored to receive the 2023 Early Career Investigator Award by @ESGCT at the Annual Congress in Brussels together with @alessionahmad. This prestigious recognition would not have been possible without my SR-Tiget colleagues and mentors @NaldiniLab and @Genovese_Lab.
Excited to share our latest publication about epitope editing in hematopoietic stem cells to enable targeted immunotherapy for acute myeloid leukemia. Congrats to @CasiratiG and all collaborators for this amazing work.
https://t.co/bTx6YoFDHJ
I'm thrilled to announce that our work, 'Epitope Editing Enables Targeted Immunotherapy of Acute Myeloid Leukemia,' is out today in Nature journal!
Link: https://t.co/nC05EjWMPw
doi: https://t.co/t8CWop6Z4k
Congrats to Zeng @Genovese_Lab@danielevanbauer et al. on their paper "Base Editing of Human Hematopoietic Stem Cells."
Thanks for using #crispresso2! https://t.co/Wo18eIm0dd
With #geneediting, researchers restored levels of CTLA-4 in T cells from patients with CTLA-4 insufficiency. In mice, they improved symptoms.
ASGCT members involved: @RealDrfox, MbChB, PhD; Claire Booth, MBBS, PhD; Pietro Genovese @Genovese_Lab, PhD: https://t.co/BQUs3JX4mw.
"Unless things change dramatically, the millions of people #CRISPR could save will never benefit from it. We must, and we can, build a world with #CRISPR for all."
#healthjustice@igisci@nytimes
https://t.co/7VjfFdkLzJ
Researchers at @SanRaffaeleMI, led by Dr. Maria Ester Bernardo, developed an MSC-based co-culture system to optimize the transplantation outcome of #CRISPR-Cas9 gene-edited human #hematopoietic stem and progenitor cells. 🧬
#OpenAccess | 🔗 https://t.co/SpOmcmo4Cg
These are exciting but hard times for #genetherapy . It’s heartbreaking to witness withdrawal of effective gene therapies from the market. They are often the only cure for many rare conditions, saving lives of other human beings.
Don’t miss this!